Determination of topological structure of ARL6ip1 in cells: Identification of the essential binding region of ARL6ip1 for conophylline

Authors:
  • SFShintaro Funasaki
    Shintaro Funasaki
  • TSTsuyoshi Saitoh
    Tsuyoshi Saitoh
  • YSYukiko Sasazawa
    Yukiko Sasazawa
  • SNShigeru Nishiyama
    Shigeru Nishiyama
  • KUKazuo Umezawa
    Kazuo Umezawa
  • SSSiro Simizu
    Siro Simizu

Abstract
Conophylline (CNP) has various biological activities, such as insulin production. A recent study identified ADP‐ribosylation factor‐like 6‐interacting protein 1 (ARL6ip1) as a direct target protein of CNP. In this study, we revealed that ARL6ip1 is a three‐spanning transmembrane protein and determined the CNP‐binding domain of ARL6ip1 by deletion mutation analysis of ARL6ip1 with biotinyl‐amino‐CNP. These results suggest that CNP is expected to be useful for future investigation of ARL6ip1 function in cells. Because of the anti‐apoptotic function of ARL6ip1, CNP may be an effective therapeutic drug and/or a novel chemosensitizer for human cancers and other diseases.
Funding Information
  • Grant-in-Aid for Scientific Research (B) (23310163, 24310167)
  • Grant-in-Aid for Young Scientists (24810025)
  • Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan
  • Nateglinide Memorial Toyoshima Research and Education Fund of Keio University

This publication has 17 references indexed in Scilit: